Browse Helios by "Author"
Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page
Showing results 1 to 6 of 6

DateTitleAuthor(s)Full text
2007Novel pharmacological compounds as triggers of ischemic preconditioning in vivoAndreadou, I.; Fotopoulou, T.; Koufaki, Maria; Tsotinis, A.; Zoga, A.; Gizas, V.; Iliodromitis, E.; Kremastinos, D. T.
2006Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analoguesMavromoustakos, Thomas; Moutevelis-Minakakis, P.; Kokotos, C. G.; Kontogianni, P.; Politi, A.; Zoumpoulakis, Panagiotis; Findlay, J.; Cox, A.; Balmforth, A.; Zoga, A.; Iliodromitis, E.
2003Design, conformation and bioactivity of novel angiotensin II receptor antagonistsMavromoustakos, Thomas; Zoumpoulakis, Panagiotis; Roumelioti, P.; Giatas, N.; Zoga, A.; Vlahakos, D.; Iliodromitis, E.; Matsoukas, J.
2003Conformational and biological studies for a pair of novel synthetic AT(1) antagonists: stereoelectronic requirements for antihypertensive efficacyZoumpoulakis, Panagiotis; Zoga, A.; Roumelioti, P.; Giatas, N.; Grdadolnik, S. G.; Iliodromitis, E.; Vlahakos, D.; Kremastinos, D.; Matsoukas, J. M.; Mavromoustakos, Thomas
2003Design and synthesis of novel antihypertensive drugsMoutevelis-Minakakis, P.; Gianni, M.; Stougiannou, H.; Zoumpoulakis, Panagiotis; Zoga, A.; Vlahakos, A. D.; Iliodromitis, E.; Mavromoustakos, Thomas
2002Design, synthesis and biological evaluation of cyclic Angiotensin II analogues with 3,5 side-chain bridges: Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonistsRoumelioti, P.; Polevaya, L.; Zoumpoulakis, Panagiotis; Giatas, N.; Mutule, I.; Keivish, T.; Zoga, A.; Vlahakos, D.; Iliodromitis, E.; Kremastinos, D.; Grdadolnik, S. G.; Mavromoustakos, Thomas; Matsoukas, J.
Showing results 1 to 6 of 6


Follow EKT at: